Innovia Medical, Inc.

Innovia Medical, Inc. was founded in 2015 and is headquartered in St. Paul, US. The company specializes in medical devices for surgical procedures.

In July 2025, Innovia Medical LLC, a portfolio company of Inverness Graham Investments, acquired Hurricane Medical. The current CEO is Terry Meredith. Innovia Medical specializes in the development and distribution of specialty surgical products, primarily focusing on aesthetic and reconstructive surgery, ear, nose, and throat (ENT) procedures, and ophthalmology. Their core product offerings include single-use instruments such as the Cervical Rotating Biopsy Punch, designed to enhance patient comfort and reduce trauma during gynecological procedures, and the CORONET® Corneal Trephines, which utilize unique blade technology for precision in corneal surgeries.

Additionally, products like the Rhino Rocket® nasal packing device address epistaxis management, demonstrating the company's commitment to improving patient outcomes. Innovia Medical’s products are utilized by healthcare professionals across over 70 countries, including markets in the United States, Canada, the United Kingdom, and several nations in Europe and Asia, catering to hospitals, clinics, and surgical centers. Innovia Medical operates primarily through a B2B transactional model, serving healthcare organizations, medical device distributors, and surgical centers. The company's revenue is generated from the direct sale of its medical devices and instruments, including flagship products like the Tissu-Trans® device and various ENT surgical instruments.

Transactions typically involve bulk purchases by healthcare facilities and ongoing partnerships with distributors who supply Innovia's products to end-users. Pricing structures are based on negotiated contracts reflecting the volume of orders, with specialized customized instrument trays offered to meet specific client needs. The company leverages its extensive product range and reputation for quality to foster long-term relationships with clients, thus securing a stable revenue stream through repeat purchases and tailored solutions. Following the acquisition on March 31, 2023, Innovia Medical, Inc.

aims to enhance its product offerings and expand its market presence. The company plans to introduce new surgical products in the near future, focusing on advanced technologies to improve surgical outcomes. Additionally, Innovia Medical is targeting expansion into emerging markets in Asia and Europe by the end of 2024. The recent acquisition will support these growth initiatives, allowing for increased investment in product development and market penetration.